Our findings suggest that TM peptides provide an experimental basis for further research into the etiology of depression and represent new candidate small molecules that could be used to interfere with 5-HT1AR/OX1R dimerization for the treatment of depression. The gene discussed is HCRTR1; the disease is depressive symptom measurement.